Atopic disorders among Estonian schoolchildren in relation to tuberculin reactivity and the age at BCG vaccination

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 10, 2004, Pages 1068-1073

  Annus, Triine ^a,e   Montgomery, S M ^b   Riikjarv M A ^c   Bjorksten B ^d  

^a Tartu University Children's Hospital   (Estonia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c TALLINN CHILDREN S HOSPITAL   (Estonia)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Tallinn Child Hosp Ctrl Policlin   (Estonia)

Author keywords

Asthma; Atopy; BCG vaccination; International Study of Asthma and Allergies in Childhood (ISAAC); Schoolchildren; Tuberculin reactivity

Indexed keywords

BCG VACCINE;

ALLERGY; ARTICLE; ASTHMA; ATOPY; BCG VACCINATION; CONTROLLED STUDY; CORRELATION ANALYSIS; COUGHING; ECZEMA; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; PROTECTION; QUESTIONNAIRE; SCHOOL CHILD; SKIN TEST; SYMPTOMATOLOGY; TUBERCULIN TEST;

AGE FACTORS; BCG VACCINE; CHILD; ESTONIA; HUMANS; HYPERSENSITIVITY; PREVALENCE; SKIN TESTS; TUBERCULIN;

EID: 4644234193     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00557.x     Document Type: Article

References (36)

1. COOKSON WO, MOFFATT MF. Asthma: an epidemic in the absence of infection? Science 1997;275:41-42.
2. ERB KJ, HOLLOWAY JW, SOBECK A, MOLL H, LE GROS G. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J Exp Med 1998;187:561-569.
3. HERZ U, GERHOLD K, GRÜBER C, BRAUN A, WAHN U, RENZ H et al. BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998;102:867-874.
4. KOH YI, CHOI IS, KIM WY. BCG infection in allergen-presensitized rats suppresses Th2 immune response and prevents the development of allergic asthmatic reaction. J Clin Immunol 2001;21:51-59.
5. HOPFENSPIRGER MT, AGRAWAL DK. Airway hyperresponsiveness, late allergic response, and eosinophilia are reversed with mycobacterial antigens in ovalbumin-presensitized mice. J Immunol 2002;168:2516-2522.
6. YANG X, FAN Y, WANG S, HAN X, YANG J, BILENKI L et al. Mycobacterial infection inhibits established allergic inflammatory responses via alteration of cytokine production and vascular cell adhesion molecule-1 expression. Immunology 2002;105:336-343.
7. VON MUTIUS E, PEARCE N, BEASLEY R, CHENG S, von EHRENSTEIN O, BJÖRKSTÉN B et al. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax 2000;55:449-453.
8. ANDERSON HR, POLONIECKI JD, STRACHAN DP, BEASLEY R, BJÖRKSTÉN B, ASHER MI. Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. Am J Public Health 2001;91:1126-1129.
9. von HERTZEN L, KLAUKKA T, MATTILA H, HAAHTELA T. Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions. J Allergy Clin Immunol 1999;104:1211-1214.
10. AABY P, SHAHEEN SO, HEYES CB, GOUDIABY A, HALL AJ, SHIELL AW et al. Early BCG vaccination and reduction in atopy in Guinea-Bissau. Clin Exp Allergy 2000;30:644-650.
11. GRÜBER C, MEINLSCHMIDT G, BERGMANN R, WAHN U, STARK K. Is early BCG vaccination associated with less atopic disease? An epidemiological study in German preschool children with different ethnic backgrounds. Pediatr Allergy Immunol 2002;13:177-181.
12. GRÜBER C, KULIG M, BERGMANN R, GUGGENMOOS-HOLZMANN I, WAHN U. Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization, and atopic manifestation in longitudinally followed early Bacille Calmette-Guerin-vaccinated and nonvaccinated children. Pediatrics 2001;107:E36.
13. ALM JS, LILJA G, PERSHAGEN G, SCHEYNIUS A. Early BCG vaccination and development of atopy. Lancet 1997;350:400-403.
14. STRANNEGÅRD IL, LARSSON LO, WENNERGREN G, STRANNEGÅRD Ö. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria. Allergy 1998;53:249-254.
15. ARKWRIGHT PD, DAVID TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol 2001;107:531-534.
16. CHOI IS, KOH YI. Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial. Ann Allergy Asthma Immunol 2002;88:584-591.
17. MATRICARDI PM, BJÖRKSTÉN B, BONINI S, BOUSQUET J, DJUKANOVIC R, DREBORG S et al. Microbial products in allergy prevention and therapy. Allergy 2003;58:461-471.
18. SHIRAKAWA T, ENOMOTO T, SHIMAZU S, HOPKIN JM. The inverse association between tuberculin responses and atopic disorder. Science 1997;275:77-79.
19. MARTINATI LC, BONER AL. The inverse relationship between tuberculin responses and atopic disorder. Allergy 1997;52:1036-1037.
20. OMENAAS E, JENTOFT HF, VOLLMER WM, BUIST AS, GULSVIK A. Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax 2000;55:454-458.
21. WONG GW, HUI DS, TAM CM, CHAN HH, FOK TF, CHAN-YEUNG M et al. Asthma, atopy and tuberculin responses in Chinese schoolchildren in Hong Kong. Thorax 2001;56:770-773.
22. YILMAZ M, BINGÖL G, ALTINTAS D, KENDIRLI SG. Correlation between atopic diseases and tuberculin responses. Allergy 2000;55:664-667.
23. JENTOFT HF, OMENAAS E, EIDE GE, GULSVIK A. Absence of relationship between tuberculin reactivity and asthmatic symptoms, level of FEV1 and bronchial hyperresponsiveness in BCG vaccinated young adults. Allergy 2002;57:336-340.
24. OZMEN S, TOMAC N, UYSAL A, ARSLAN Z, KUYUCU N, YONEY A. Tuberculin responses in children with allergic diseases. Allergy 2002;57:1059-1062.
25. JULGE K, MERISTE S, KEMP A, BJÖRKSTÉN B. Atopic allergy and delayed type hypersensitivity in Estonian children. Clin Exp Allergy 2002;32:1420-1423.
26. Statistical Office of Estonia. Statistical Yearbook of Estonia 1998. Tallinn: Statistical Office of Estonia, 1998.
27. BJÖRKSTÉN B, DUMITRASCU D, FOUCARD T, KHETSURIANI N, KHAITOV R, LEJA M et al. Prevalence of childhood asthma, rhinitis and eczema in Scandinavia and Eastern Europe. Eur Respir J 1998;12:432-437.
28. JOGI R, JANSON C, BJÖRNSSON E, BOMAN G, BJÖRKSTÉN B. Atopy and allergic disorders among adults in Tartu, Estonia compared with Uppsala, Sweden. Clin Exp Allergy 1998;28:1072-1080.
29. RIIKJÄRV MA, ANNUS T, BRÅBÄCK L, RAHU K, BJÖRKSTÉN B. Similar prevalence of respiratory symptoms and atopy in Estonian schoolchildren with changing lifestyle over 4 yrs. Eur Respir J 2000;16:86-90.
30. HOLT PG, SLY PD, BJÖRKSTÉN B. Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol 1997;8:53-58.
31. MARTINEZ FD, HOLT PG. Role of microbial burden in aetiology of allergy and asthma. Lancet 1999;354 (Suppl 2):S1112-15.
32. LEHMANN I, THOELKE A, WEISS M, SCHLINK U, SCHULZ R, DIEZ U et al. T cell reactivity in neonates from an East and a West German city - results of the LISA study. Allergy 2002;57:129-136.
33. PRESCOTT SL, MACAUBAS C, SMALLACOMBE T, HOLT BJ, SLY PD, HOLT PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999;353:196-200.
34. KERO J, GISSLER M, HEMMINKI E, ISOLAURI E. Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol 2001;108:781-783.
35. SIMPSON CR, ANDERSON WJ, HELMS PJ, TAYLOR MW, WATSON L, PRESCOTT GJ et al. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy 2002;32:37-42.
36. SMART JM, KEMP AS. Increased Th1 and Th2 allergen-induced cytokine responses in children with atopic disease. Clin Exp Allergy 2002;32:796-802.